Substance Use in Pregnancy - Optimizing Retention in Treatment (NCT07104123)
Substance Use in Pregnancy - Optimizing Retention in Treatment by Maximizing Opportunities for Management
🩺 Plain-English Summary (8th-Grade Level)
Substance use during pregnancy is a leading cause of maternal morbidity and mortality in the United States, with 55-80% of postpartum patients disengaging from substance use disorder (SUD) treatment within one year of delivery. Structural and social determinants of health, including housing instability, transportation barriers, and limited childcare access, further exacerbate disparities in treatment retention. This pilot study, conducted in two specialized prenatal care clinics, evaluates the feasibility and acceptability of two integrated strategies to promote sustained engagement in recovery-oriented services during the perinatal and postpartum periods. Aim 1 implements a standardized social needs screening and referral protocol to connect patients with community-based supports. Aim 2 pilots a contingency management intervention to incentivize recovery-supportive behaviors. Findings will inform the design of a larger multi-site randomized controlled trial to evaluate the impact of these interventions on treatment retention, overdose prevention, and maternal-infant health outcomes.
Who can join: Review the eligibility criteria below.
Location: University of Maryland — Baltimore, Maryland
Age range: 18 Years
🧪 Interventions in This Study
- Social drivers of health screening (OTHER)
- Patients will undergo a program of contingency management (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- University of Maryland — Baltimore, Maryland
- Washington University — St Louis, Missouri
📞 Contact the Study Coordinator
Phone: (314) 273-2279
Email: melissa.mills@wustl.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Substance Use Disorder (SUD)
- Reentry Assist (R-Assist) — Worcester, Massachusetts
- Justice Community Overdose Innovation Network II TCU Hub — Fort Worth, Texas
- Real-time Opioid Study — New Haven, Connecticut
- Preventing Overdose and Promoting Recovery Through Court Navigation — South Bend, Indiana
- Engaging Family Members During Early SUD Treatment: A Hybrid Trial — San Diego, California
- Recovery Works - Facilitating Sustainable Recovery Through Workforce — Lewisburg, West Virginia
Explore by condition: All Substance Use Disorder (SUD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.